Investigational Drug Information for MGL-3196
✉ Email this page to a colleague
What is the drug development status for MGL-3196?
MGL-3196 is an investigational drug.
There have been 12 clinical trials for MGL-3196.
The most recent clinical trial was a Phase 2 trial, which was initiated on December 16th 2019.
The most common disease conditions in clinical trials are Non-alcoholic Fatty Liver Disease, Fatty Liver, and Liver Diseases. The leading clinical trial sponsors are Madrigal Pharmaceuticals, Inc., Celerion, and Worldwide Clinical Trials.
There are four US patents protecting this investigational drug and one hundred and thirteen international patents.
Summary for MGL-3196
| US Patents | 4 |
| International Patents | 113 |
| US Patent Applications | 51 |
| WIPO Patent Applications | 42 |
| Japanese Patent Applications | 4 |
| Clinical Trial Progress | Phase 2 (2019-12-16) |
| Vendors | 52 |
Recent Clinical Trials for MGL-3196
| Title | Sponsor | Phase |
|---|---|---|
| A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE) | Madrigal Pharmaceuticals, Inc. | Phase 3 |
| A Phase 3 Study to Evaluate the Safety and Biomarkers of Resmetirom (MGL-3196) in Non Alcoholic Fatty Liver Disease (NAFLD) Patients | Madrigal Pharmaceuticals, Inc. | Phase 3 |
| Drug Interaction Study of MGL-3196 With Clopidogrel | Madrigal Pharmaceuticals, Inc. | Phase 1 |
Clinical Trial Summary for MGL-3196
Top disease conditions for MGL-3196
Top clinical trial sponsors for MGL-3196
US Patents for MGL-3196
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| MGL-3196 | ⤷ Sign Up | Methods of synthesizing thyroid hormone analogs and polymorphs thereof | ⤷ Sign Up | |
| MGL-3196 | ⤷ Sign Up | Thyroid hormone analogs | Hoffmann-La Roche Inc. (Nutley, NJ) | ⤷ Sign Up |
| MGL-3196 | ⤷ Sign Up | Thyroid hormone analogs | Hoffmann-La Roche Inc. (Nutley, NJ) | ⤷ Sign Up |
| MGL-3196 | ⤷ Sign Up | Method of synthesizing thyroid hormone analogs and polymorphs thereof | ⤷ Sign Up | |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for MGL-3196
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| MGL-3196 | Argentina | AR092872 | 2032-09-17 | ⤷ Sign Up |
| MGL-3196 | Australia | AU2013315017 | 2032-09-17 | ⤷ Sign Up |
| MGL-3196 | Brazil | BR112015005891 | 2032-09-17 | ⤷ Sign Up |
| MGL-3196 | Brazil | BR122021024202 | 2032-09-17 | ⤷ Sign Up |
| MGL-3196 | Canada | CA2884481 | 2032-09-17 | ⤷ Sign Up |
| MGL-3196 | Canada | CA3090070 | 2032-09-17 | ⤷ Sign Up |
| MGL-3196 | Canada | CA3111317 | 2032-09-17 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
